These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Spectrofluorimetric study of the intermolecular complexation of monoclonal antibodies with the high potency sweetener N-(p-cyanophenyl)-N'-(diphenylmethyl) guanidineacetic acid. Droupadi PR; Anchin JM; Meyers EA; Linthicum DS J Mol Recognit; 1992 Dec; 5(4):173-9. PubMed ID: 1339485 [TBL] [Abstract][Full Text] [Related]
9. Recognition of superpotent sweetener ligands by a library of monoclonal antibodies. Anchin JM; Nagarajan S; Carter J; Kellogg MS; DuBois GE; Linthicum DS J Mol Recognit; 1997; 10(5):235-42. PubMed ID: 9587873 [TBL] [Abstract][Full Text] [Related]
10. Analysis of correlated motion in antibody combining sites from molecular dynamics simulations. Viswanathan M; Linthicum DS; Subramaniam S Methods; 2000 Mar; 20(3):362-71. PubMed ID: 10694457 [TBL] [Abstract][Full Text] [Related]
11. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins. Guddat LW; Shan L; Broomell C; Ramsland PA; Fan Z; Anchin JM; Linthicum DS; Edmundson AB J Mol Biol; 2000 Sep; 302(4):853-72. PubMed ID: 10993728 [TBL] [Abstract][Full Text] [Related]
12. Absorption spectroscopy of the complexation between superpotent guanidinium sweeteners and specific monoclonal antibodies. Droupadi PR; Linthicum DS Int J Biochem Cell Biol; 1995 Apr; 27(4):351-7. PubMed ID: 7788557 [TBL] [Abstract][Full Text] [Related]
13. Variable region sequence and characterization of monoclonal antibodies to a N,N',N"-trisubstituted guanidine high potency sweetener. Anchin JM; Linthicum DS Mol Immunol; 1993 Nov; 30(16):1463-71. PubMed ID: 8232332 [TBL] [Abstract][Full Text] [Related]
14. Construction and characterization of two anti-sweetener single chain antibodies using radioligand binding, fluorescence and circular dichroism spectroscopy. Pledger DW; Brodnicki TC; Graham BL; Tetin S; Kranz DM; Linthicum DS J Mol Recognit; 1999; 12(4):258-66. PubMed ID: 10440997 [TBL] [Abstract][Full Text] [Related]
15. Bimolecular reaction simulation using Weighted Ensemble Brownian dynamics and the University of Houston Brownian Dynamics program. Rojnuckarin A; Livesay DR; Subramaniam S Biophys J; 2000 Aug; 79(2):686-93. PubMed ID: 10920003 [TBL] [Abstract][Full Text] [Related]
16. Local and transmitted conformational changes on complexation of an anti-sweetener Fab. Guddat LW; Shan L; Anchin JM; Linthicum DS; Edmundson AB J Mol Biol; 1994 Feb; 236(1):247-74. PubMed ID: 7893280 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the binding site architecture of monoclonal antibodies to morphine by using competitive ligand binding and molecular modeling. Kussie PH; Anchin JM; Subramaniam S; Glasel JA; Linthicum DS J Immunol; 1991 Jun; 146(12):4248-57. PubMed ID: 2040800 [TBL] [Abstract][Full Text] [Related]
18. Investigation of the stereoselectivity of an anti-amino acid antibody using molecular modeling and ligand docking. Ranieri DI; Corgliano DM; Franco EJ; Hofstetter H; Hofstetter O Chirality; 2008 Mar; 20(3-4):559-70. PubMed ID: 18172831 [TBL] [Abstract][Full Text] [Related]
19. Cocrystal structures of NC6.8 Fab identify key interactions for high potency sweetener recognition: implications for the design of synthetic sweeteners. Gokulan K; Khare S; Ronning DR; Linthicum SD; Sacchettini JC; Rupp B Biochemistry; 2005 Jul; 44(29):9889-98. PubMed ID: 16026161 [TBL] [Abstract][Full Text] [Related]
20. Identification of important residues in metal-chelate recognition by monoclonal antibodies. Delehanty JB; Jones RM; Bishop TC; Blake DA Biochemistry; 2003 Dec; 42(48):14173-83. PubMed ID: 14640685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]